IP Library Granted Patent US 12,441,965
Granted Patent B2
US 12,441,965 · App. 18/158,544 · Granted Oct 14, 2025

Treatment liquid and substrate washing method

Inventors: Yasuo Sugishima (Shizuoka, JP); Atsushi Mizutani (Shizuoka, JP)
Assignee: FUJIFILM Corporation
C11D7/5022C11D3/184C11D3/2044C11D3/30C11D7/244C11D7/261C11D7/267C11D7/3209C11D7/3218C11D7/50H01L21/02057C11D2111/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,441,965
App. No.
18/158,544
Granted
Oct 14, 2025
Kind
B2
Abstract

An object of the present invention is to provide a treatment liquid for a semiconductor device, which is excellent in removal performance for residues present on a substrate, and to provide a substrate washing method using the treatment liquid. The treatment liquid of the present invention is a treatment liquid for a semiconductor device, which includes water, a basic compound, hexylene glycol, and a compound A that is at least one kind selected from the group consisting of isobutene, (E)-2-methyl-1,3-pentadiene, 4-methyl-1,3-pentadiene, 2,2,4-trimethyloxetane, 4-methyl-3-penten-2-ol, and 2,4,4,6-tetramethyl-1,3-dioxane.

Claims (51)

1. A treatment liquid for a semiconductor device, comprising:

water;

a basic compound;

hexylene glycol; and

a compound A that is at least one kind selected from the group consisting of isobutene, (E)-2-methyl-1,3-pentadiene, 4-methyl-1,3-pentadiene, 2,2,4-trimethyloxetane, 4-methyl-3-penten-2-ol, and 2,4,4,6-tetramethyl-1,3-dioxane.

2. The treatment liquid according to claim 1 ,

wherein in a case where the treatment liquid comprises one kind of the compound A, a content of the compound A with respect to a total mass of the treatment liquid is 1,000 ppm by mass or less, and

in a case where the treatment liquid comprises two or more kinds of the compounds A, a content of each of the compounds A with respect to the total mass of the treatment liquid is 1,000 ppm by mass or less.

3. The treatment liquid according to claim 1 ,

wherein the treatment liquid comprises two or more kinds of the compounds A, and

in the treatment liquid, in a case where a content of a compound having a highest content among the compounds A is denoted by α and a content of a compound having a second highest content among the compounds A is denoted by β, a ratio α/β of the content α to the content β is less than 10 in terms of mass ratio.

4. The treatment liquid according to claim 1 ,

wherein the treatment liquid comprises three or more kinds of the compounds A, and

in the treatment liquid, in a case where a content of a compound having a second highest content among the compounds A is denoted by β and a content of a compound having a third highest content among the compounds A is denoted by γ, a ratio β/γ of the content β to the content γ is less than 10 in terms of mass ratio.

5. The treatment liquid according to claim 1 ,

wherein the treatment liquid comprises at least one kind selected from the group consisting of isobutene, 4-methyl-1,3-pentadiene, 2,2,4-trimethyloxetane, and 4-methyl-3-penten-2-ol.

6. The treatment liquid according to claim 1 ,

wherein a content of the hexylene glycol in the treatment liquid is 60% by mass or more with respect to a total mass of the treatment liquid.

7. The treatment liquid according to claim 1 ,

wherein the basic compound comprises at least one selected from the group consisting of tetramethylammonium hydroxide, monoethanolamine, and hydroxylamine.

8. The treatment liquid according to claim 1 ,

wherein the basic compound comprises a compound B represented by Formula (1),

NH 2 —CH 2 CH 2 —X—CH 2 CH 2 —Y  (1)

in Formula (1), X represents —NR— or —O—, R represents a hydrogen atom or a substituent, and Y represents a hydroxy group or a primary amino group.

9. The treatment liquid according to claim 8 ,

wherein the compound B comprises at least one selected from the group consisting of 2-(2-aminoethylamino)ethanol, 2,2′-oxybis(ethylamine), and 2-(2-aminoethoxy)ethanol.

10. The treatment liquid according to claim 8 ,

wherein a content of the compound B with respect to a total mass of the treatment liquid is 0.1% to 1.15% by mass.

11. The treatment liquid according to claim 1 ,

wherein the basic compound comprises two or more kinds of amine compounds.

12. The treatment liquid according to claim 11 ,

wherein in the treatment liquid, a ratio of a content of a compound having a highest content among the amine compounds to a content of an amine compound having a lowest content among the amine compounds is 9 to 100 in terms of mass ratio.

13. The treatment liquid according to claim 1 ,

wherein the treatment liquid is used as a washing solution for removing etching residues from a substrate including a metal-containing layer or as a washing solution for removing residues from a substrate after chemical mechanical polishing.

14. A substrate washing method comprising a washing step of washing a substrate comprises a metal-containing layer, by contacting the substrate with the treatment liquid according to claim 1 .

15. The treatment liquid according to claim 2 ,

wherein the treatment liquid comprises two or more kinds of the compounds A, and

in the treatment liquid, in a case where a content of a compound having a highest content among the compounds A is denoted by α and a content of a compound having a second highest content among the compounds A is denoted by β, a ratio α/β of the content α to the content β is less than 10 in terms of mass ratio.

16. The treatment liquid according to claim 2 ,

wherein the treatment liquid comprises three or more kinds of the compounds A, and

in the treatment liquid, in a case where a content of a compound having a second highest content among the compounds A is denoted by β and a content of a compound having a third highest content among the compounds A is denoted by γ, a ratio β/γ of the content β to the content γ is less than 10 in terms of mass ratio.

17. The treatment liquid according to claim 2 ,

wherein the treatment liquid comprises at least one kind selected from the group consisting of isobutene, 4-methyl-1,3-pentadiene, 2,2,4-trimethyloxetane, and 4-methyl-3-penten-2-ol.

18. The treatment liquid according to claim 2 ,

wherein a content of the hexylene glycol in the treatment liquid is 60% by mass or more with respect to a total mass of the treatment liquid.

19. The treatment liquid according to claim 2 ,

wherein the basic compound comprises at least one selected from the group consisting of tetramethylammonium hydroxide, monoethanolamine, and hydroxylamine.

20. The treatment liquid according to claim 2 ,

wherein the basic compound comprises a compound B represented by Formula (1),

NH 2 —CH 2 CH 2 —X—CH 2 CH 2 —Y  (1)

in Formula (1), X represents —NR— or —O—, R represents a hydrogen atom or a substituent, and Y represents a hydroxy group or a primary amino group.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2023
From: SUGISHIMA, YASUO; MIZUTANI, ATSUSHI
To: FUJIFILM CORPORATION
Reel/Frame 062464/0812 →
Priority Claims (2)
JP 2020-128876 · Jul 30, 2020 · national
JP 2021-026410 · Feb 22, 2021 · national
Continuity (2)
Continuation PCTJP2021023966 · Jun 24, 2021
Related Publication 20230212485A1 · Jul 6, 2023
References Cited (12)
US 8236485B2 · Minsek · 2012 [cited by examiner]
US 20140109931A1 · Lee et al. · 2014 [cited by applicant]
US 20160186106A1 · Du · 2016 [cited by examiner]
US 20190062674A1 · Dory · 2019 [cited by examiner]
US 20190079409A1 · Takahashi et al. · 2019 [cited by applicant]
JP 200845119A · 2006 [cited by applicant]
JP 2018164091A · 2018 [cited by applicant]
WO 2017208767A1 · 2017 [cited by applicant]
International Preliminary Report on Patentability dated Jan. 31, 2023 with a Translation of the Written Opinion of the International Searching Authority in Application No. PCT/JP2021/023966. [cited by applicant]
International Search Report dated Sep. 7, 2021 in Application No. PCT/JP2021/023966. [cited by applicant]
Written Opinion of the International Searching Authority dated Sep. 7, 2021 in Application No. PCT/JP2021/023966. [cited by applicant]
Communication dated Nov. 28, 2023 issued by the Japanese Patent Office in application No. 2022-540073. [cited by applicant]